BeiGene
BGNE
$148.85
Share price
-3.50%
Change (1 day)
-33.39%
Change (1 year)
Categories
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.
BeiGene (BGNE) - Cost to borrow shares
Latest borrow fee for BeiGene (BGNE) shares on Interactive Brokers: 0.4033% (annualized)
Shares available to borrow: 100000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
BeiGene (BGNE) - cost to borrow in the last 7 days chart
BeiGene (BGNE) - number of shares available to borrow in the last 7 days
BeiGene (BGNE) - cost to borrow from 2024 to 2023
BeiGene (BGNE) - number of shares available to borrow from 2024 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 OPKO Health
OPK | 6.0312% | 0.3 M | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 15.3779% | 0.7 M | 🇺🇸 USA |